Euronews.
By Euronews with AP
The EU’s medicines agency has recommended the approval of the Pfizer-BioNTech COVID vaccine for 5-11-year-olds.
The European Medicines Agency said in a statement that it had made the decision after concluding that “the benefits of Comirnaty in children aged 5 to 11 outweigh the risks, particularly in those with conditions that increase the risk of severe COVID-19”.
The dose injected to that age group will be “lower than that used in people aged 12 and above”, the agency said.